← Evidence map

ArticlePharmacoEconomics2010

Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.

Andrew M Hill et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2010

this papercites it

Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER. | OpenQuestion